The following table details the trading activities
(stock purchases, stock sales, and stock option exercises)
the Securities and Exchange Commission (SEC)
by insider Nashat Amir since year 2005.
The trader's CIK number is 1575843.
At the time of this reporting, Nashat Amir is the Director of Selecta Biosciences Inc .
(stock ticker symbol SELB).
See this page for all insider trading activities at Selecta Biosciences Inc .
|Trade Date||Symbol||Company Name (Issuer)||Trade Type||Shares||Price ($)||Value ($)|
|2017-09-26||SELB||Selecta Biosciences Inc||Sale||70,226||18.91||1,328,114|
|2017-09-22||SELB||Selecta Biosciences Inc||Sale||42,036||19.26||809,781|
|2017-09-25||SELB||Selecta Biosciences Inc||Sale||37,175||18.99||705,878|
|2017-09-20||SELB||Selecta Biosciences Inc||Sale||42,610||20.03||853,393|
|2017-09-21||SELB||Selecta Biosciences Inc||Sale||104,577||19.86||2,076,794|
|2016-07-06||SYRS||Syros Pharmaceuticals, Inc.||Buy||400,000||12.50||5,000,000|
|2016-06-27||SELB||Selecta Biosciences Inc||Buy||150,000||14.00||2,100,000|
|2013-10-04||FATE||Fate Therapeutics Inc||Buy||833,333||6.00||4,999,998|
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Nashat Amir (Director of Selecta Biosciences Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.